Skip to main content

GOLDMAN SACHS GROUP INC

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 886982 NEW YORK, NY

Position in HRTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$571,792
-$273,762 QoQ
Shares Held
1,329,754
+25.8% QoQ
Ownership
0.700%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in HRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. HRTX ranks #278 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HRTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $571,792 1,329,754
2026-03-31 $845,554 1,056,944
2025-12-31 $1,286,733 989,796
2025-09-30 $1,669,248 1,324,802
2025-06-30 $2,159,650 1,043,310
2025-03-31 $2,263,090 1,028,678
2024-12-31 $1,002,394 655,160
2024-09-30 $3,397,231 1,707,152
2024-06-30 $4,952,740 1,415,069
2024-03-31 $3,879,118 1,400,404
2023-12-31 $1,673,904 984,651
2023-09-30 $623,978 605,806
2023-06-30 $656,632 566,064
2023-03-31 $610,505 404,309
2022-12-31 $2,882,377 1,152,951
2022-09-30 $9,702,002 2,299,053
2022-06-30 $3,556,409 1,274,699
2022-03-31 $13,039,299 2,279,598
2021-12-31 $17,515,081 1,918,410
2021-09-30 $17,123,839 1,601,856
2021-06-30 $10,754,831 692,966
2021-03-31 $19,861,869 1,225,285
2020-12-31 $24,301,931 1,147,942
2020-09-30 $15,308,822 1,032,984
2020-06-30 $17,460,108 1,186,955
2020-03-31 $17,440,086 1,485,527